A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy

BACKGROUND: Dysthyroid optic neuropathy (DON) is a serious threatening vision loss in Graves’ ophthalmopathy (GO). Although the European Group on Graves’ Ophthalmopathy (EUGOGO) recommend intravenous methylprednisolone therapy for first line treatment, some characteristics predicting the response ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Kemchoknatee, Parinee, Tangon, Duanghathai, Srisombut, Thansit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869532/
https://www.ncbi.nlm.nih.gov/pubmed/36690985
http://dx.doi.org/10.1186/s12886-023-02789-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869532/
https://www.ncbi.nlm.nih.gov/pubmed/36690985
http://dx.doi.org/10.1186/s12886-023-02789-5

Ejemplares similares